Chia Nan University of Pharmacy & Science Institutional Repository:Item 310902800/22983
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 18034/20233 (89%)
Visitors : 23370312      Online Users : 507
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    CNU IR > Chna Nan Annual Bulletin > Vol.23 (1997) >  Item 310902800/22983
    Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/22983


    Title: Relative Bioavailability Study of Norfloxacin Tablets
    Norfloxacin錠劑相對生體可用率之研究
    Authors: Kuo-Chun Sung
    Ya-Ching Changchein
    Yu-Wei Shen
    Long-Shiuh Chen
    Chung-Lung Lu
    Yu-Ying Lin
    Rough-Yee Han
    Contributors: 藥學系
    共同科
    Keywords: Norfloxacin
    Relative bioavallability
    Bioequivalence
    相對生體可用率
    生體相等性
    Date: 1997
    Issue Date: 2010-08-10 10:37:46 (UTC+8)
    Abstract: The project is to study the bloequivalence of two norfloxacin tablets. The test product was Noraxin tablet (200 mg norfloxacin per tablet); the reference product was Baccidal tahlet (200 mg norfloxacin per tablet). Ten healthy adult male volunteers involved in the study. Every subject received each formulation according to a completely double-blind randomized cross-over design with more than one week wash out period between each dose. Following oral administration of 400mg of the drug (two tablets per subject), blood samples were drawn fourteen times over a period of twenty four hours. These samples were analyzed for norfloxacin concentrations using a sensitive and specific high performance liquid chromatography. Statistical assessments on various Pharmacokinetic parameters derived from the plasma drug concentration-time profiles were used to determine the bioequivalence of these two formulations. By using the ANOVA, power analysis,90% confidence interval and two one sided tests, it is concluded that Noraxin and Baccldal are bioequivalent.
    本計畫旨在評估兩種norfloxacin錠劑之生體相等性。試驗品為Noraxin錠(每錠含norfloxacin 200毫克),參考品為Baccidal錠(每錠含norfloxacin 200毫克)。十位健康成年男性自願者,以隨機雙盲交叉設計的方式投予兩種norfloxacin錠,兩次給藥間至少有一星期的洗出時間。每位受試者口服400毫克norfloxacin(兩粒norfloxacin錠)後,於二十四小時內抽血十四次,此血液樣本乃用高效液相層析儀分析其中norfloxacin之濃度。而由藥物血中濃度 — 時間曲線所得之各個藥物動力學參數則加以統計分析以評估兩種製劑之生體相等性。經由ANOVA、冪次分析、90%信賴區間以及兩個單邊試驗結果顯示Noraxin和Baccidal是具生體相等性的。
    Relation: 嘉南學報 23期: p.42-51
    Appears in Collections:[Chna Nan Annual Bulletin] Vol.23 (1997)
    [Dept. of Pharmacy] Periodical Articles
    [The Center For General Education] Periodical Articles

    Files in This Item:

    There are no files associated with this item.



    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback